Morgan Stanley’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.78B | Buy |
20,881,354
+1,635,137
| +8% | +$146M | 0.11% | 167 |
|
|
2025
Q4 | $1.52B | Buy |
19,246,217
+323,367
| +2% | +$25.4M | 0.09% | 193 |
|
|
2025
Q3 | $1.51B | Sell |
18,922,850
-1,741,836
| -8% | -$149M | 0.09% | 194 |
|
|
2025
Q2 | $1.88B | Buy |
20,664,686
+1,674,674
| +9% | +$153M | 0.12% | 147 |
|
|
2025
Q1 | $1.78B | Buy |
18,990,012
+441,010
| +2% | +$39.5M | 0.13% | 143 |
|
|
2024
Q4 | $1.69B | Buy |
18,549,002
+280,691
| +2% | +$26.8M | 0.12% | 151 |
|
|
2024
Q3 | $1.9B | Buy |
18,268,311
+331,721
| +2% | +$33.8M | 0.14% | 132 |
|
|
2024
Q2 | $1.74B | Sell |
17,936,590
-380,394
| -2% | -$35.1M | 0.13% | 143 |
|
|
2024
Q1 | $1.65B | Sell |
18,316,984
-20,494,000
| -53% | -$1.74B | 0.13% | 142 |
|
|
2023
Q4 | $3.09B | Buy |
38,810,984
+21,994,997
| +131% | +$1.65B | 0.14% | 139 |
|
|
2023
Q3 | $1.2B | Buy |
16,815,987
+514,559
| +3% | +$38.5M | 0.12% | 154 |
|
|
2023
Q2 | $1.26B | Buy |
16,301,428
+4,412,429
| +37% | +$342M | 0.12% | 160 |
|
|
2023
Q1 | $893M | Buy |
11,888,999
+518,450
| +5% | +$38.6M | 0.1% | 215 |
|
|
2022
Q4 | $896M | Buy |
11,370,549
+3,345,297
| +42% | +$251M | 0.1% | 199 |
|
|
2022
Q3 | $564M | Sell |
8,025,252
-4,617,084
| -37% | -$362M | 0.08% | 243 |
|
|
2022
Q2 | $1.01B | Buy |
12,642,336
+7,073,806
| +127% | +$553M | 0.13% | 158 |
|
|
2022
Q1 | $422M | Buy |
5,568,530
+990,877
| +22% | +$78.5M | 0.06% | 304 |
|
|
2021
Q4 | $391M | Buy |
4,577,653
+520,354
| +13% | +$40.6M | 0.05% | 353 |
|
|
2021
Q3 | $307M | Sell |
4,057,299
-340,076
| -8% | -$27M | 0.04% | 393 |
|
|
2021
Q2 | $358M | Buy |
4,397,375
+473,611
| +12% | +$38.7M | 0.05% | 354 |
|
|
2021
Q1 | $309M | Sell |
3,923,764
-385,521
| -9% | -$30.2M | 0.05% | 351 |
|
|
2020
Q4 | $368M | Buy |
4,309,285
+801,541
| +23% | +$66.3M | 0.06% | 287 |
|
|
2020
Q3 | $271M | Buy |
3,507,744
+51,820
| +1% | +$3.95M | 0.05% | 307 |
|
|
2020
Q2 | $253M | Buy |
3,455,924
+26,791
| +0.8% | +$1.9M | 0.06% | 284 |
|
|
2020
Q1 | $228M | Sell |
3,429,133
-323,324
| -9% | -$22.8M | 0.06% | 274 |
|
|
2019
Q4 | $258M | Sell |
3,752,457
-48,116
| -1% | -$3.28M | 0.06% | 306 |
|
|
2019
Q3 | $279M | Sell |
3,800,573
-695,246
| -15% | -$50.4M | 0.07% | 263 |
|
|
2019
Q2 | $322M | Sell |
4,495,819
-662,987
| -13% | -$47.1M | 0.09% | 240 |
|
|
2019
Q1 | $354M | Sell |
5,158,806
-685,279
| -12% | -$44.3M | 0.1% | 206 |
|
|
2018
Q4 | $348M | Sell |
5,844,085
-1,368,439
| -19% | -$85.6M | 0.1% | 198 |
|
|
2018
Q3 | $483M | Buy |
7,212,524
+941,008
| +15% | +$62.7M | 0.12% | 173 |
|
|
2018
Q2 | $406M | Sell |
6,271,516
-1,842,853
| -23% | -$121M | 0.11% | 189 |
|
|
2018
Q1 | $582M | Buy |
8,114,369
+276,266
| +4% | +$19.9M | 0.16% | 128 |
|
|
2017
Q4 | $591M | Buy |
7,838,103
+3,530,501
| +82% | +$258M | 0.16% | 129 |
|
|
2017
Q3 | $314M | Sell |
4,307,602
-697,166
| -14% | -$50.2M | 0.09% | 231 |
|
|
2017
Q2 | $371M | Buy |
5,004,768
+320,928
| +7% | +$23.8M | 0.11% | 196 |
|
|
2017
Q1 | $343M | Buy |
4,683,840
+63,089
| +1% | +$4.42M | 0.11% | 204 |
|
|
2016
Q4 | $302M | Sell |
4,620,751
-105,469
| -2% | -$7.23M | 0.1% | 212 |
|
|
2016
Q3 | $350M | Buy |
4,726,220
+323,103
| +7% | +$23.9M | 0.12% | 185 |
|
|
2016
Q2 | $322M | Sell |
4,403,117
-867,746
| -16% | -$61.8M | 0.12% | 195 |
|
|
2016
Q1 | $372M | Sell |
5,270,863
-425,569
| -7% | -$28.3M | 0.14% | 163 |
|
|
2015
Q4 | $379M | Sell |
5,696,432
-38,838
| -0.7% | -$2.58M | 0.14% | 169 |
|
|
2015
Q3 | $364M | Buy |
5,735,270
+844,781
| +17% | +$55.2M | 0.13% | 173 |
|
|
2015
Q2 | $320M | Sell |
4,890,489
-117,714
| -2% | -$7.99M | 0.11% | 207 |
|
|
2015
Q1 | $347M | Sell |
5,008,203
-571,976
| -10% | -$39.5M | 0.13% | 187 |
|
|
2014
Q4 | $386M | Sell |
5,580,179
-565,087
| -9% | -$38.2M | 0.14% | 166 |
|
|
2014
Q3 | $401M | Sell |
6,145,266
-1,495,101
| -20% | -$98.6M | 0.15% | 153 |
|
|
2014
Q2 | $521M | Buy |
7,640,367
+332,883
| +5% | +$22.3M | 0.2% | 101 |
|
|
2014
Q1 | $474M | Buy |
7,307,484
+96,292
| +1% | +$6.07M | 0.2% | 106 |
|
|
2013
Q4 | $470M | Buy |
7,211,192
+327,081
| +5% | +$20.9M | 0.2% | 110 |
|
|
2013
Q3 | $408M | Sell |
6,884,111
-467,040
| -6% | -$27.7M | 0.19% | 116 |
|
|
2013
Q2 | $421M | Buy |
+7,351,151
| New | +$436M | 0.21% | 106 |
|
Other funds holding CL
VCM
DAM
VPM
Morgan Stanley's CL Position: Q1 2026 in Review
Morgan Stanley increased its Colgate-Palmolive (CL) stake by 8.5% in Q1 2026, buying an estimated $146M and bringing the position to 20,881,354 shares worth $1.78B. The position accounts for 0.11% of the portfolio, ranked #167.
Morgan Stanley first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $3.09B in Q4 2023. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.
- Morgan Stanley held 20,881,354 shares of Colgate-Palmolive worth $1.78B as of Q1 2026.
- Morgan Stanley bought 1,635,137 Colgate-Palmolive shares in Q1 2026, an estimated $146M.
- Colgate-Palmolive made up 0.11% of Morgan Stanley's portfolio in Q1 2026, its #167 holding.
- Morgan Stanley first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
- Morgan Stanley's Colgate-Palmolive position peaked at $3.09B in Q4 2023.
- 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.
Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.